The inhibitory effect of serum on the growth of Torulopsis glabrata

References

1. Caroline L, Rosner F, Kozinn P J. 1969; Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia. Blood 34:441–451
   [Google Scholar]
2. Caroline L, Taschdjian C L, Kozinn P J, Schade A L. 1964; Reversal of serum fungistasis by addition of iron. Journal of Investigative Dermatology 42:415–419
   [Google Scholar]
3. Cotton F A, Wilkinson G. 1972; Advanced inorganic chemistry, a comprehensive text. , 3^rd. Wiley; New York:863–867
   [Google Scholar]
4. Esterly N B, Brammer S R, Crounse R G. 1967; The relationship of transferrin and iron to serum inhibition of Candida albicans . Journal of Investigative Dermatology 49:437–442
   [Google Scholar]
5. Greenberger N J. 1973; Effects of antibiotics and other agents on the intestinal transport of iron. American Journal of Clinical Nutrition 26:104–112
   [Google Scholar]
6. Hobbs J R. 1969; Primary immune paresis. Adinolfi M. Immunology and development Heinemann; London:114
   [Google Scholar]
7. Howard D H, Otto V. 1967; The intracellular behaviour of Torulopsisglabrata . Sabouradia 5:235–239
   [Google Scholar]
8. King R D, Khan H A, Foye J C, Greenberg J H, Jones H E. 1975; Transferrin, iron, and dermatophytes. I. Serum dermatophyte inhibitory component definitively identified as unsaturated transferrin. Journal of Laboratory and Clinical Medicine 86:204–212
   [Google Scholar]
9. Kornguth M L, Kunin C M. 1976; Binding of antibiotics to the human intracellular erythrocyte proteins hemoglobin and carbonic anhydrase. Journal of Infectious Diseases 133:185–193
   [Google Scholar]
10. Otto V, Howard D H. 1976; Further studies on the intracellular behaviour of Torulopsis glabrata . Infection and Immunity 14:433–138
    [Google Scholar]
11. Petrou M A, Rogers T R. 1985; A comparison of the activity of mepartricin and amphotericin B against yeasts. Journal of Antimicrobial Chemotherapy 16:169–178
    [Google Scholar]
12. Schade A L, Caroline L. 1946; An iron-binding component in human blood plasma. Science 104:340–341
    [Google Scholar]
13. Schultze H E, Heremans J F. 1966; Molecular biology of human proteins. 1 Elsevier; Amsterdam:
    [Google Scholar]
14. Seelig M S. 1966a; The role of antibiotics in the pathogenesis of Candida infections. American Journal of Medicine 40:889–917
    [Google Scholar]
15. Seelig M S. 1966b; Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriological Reviews 30:442–459
    [Google Scholar]
16. Seelig M S. 1968; The rationale for preventing antibacterial-induced fungal overgrowth. Medical Times 96:689–710
    [Google Scholar]
17. Summers D F, Hasenclever H F. 1964; In-vitro inhibition of yeast growth by mouse ascites fluid and serum. Journal of Bacteriology 87:1–7
    [Google Scholar]
18. Warnock D W. 1982; Immunological and other defects predisposing to fungal infection in the compromised host. Warnock D W, Richardson M D. Fungal infection in the compromised patient Wiley; Chichester:29–47
    [Google Scholar]
19. Whicher J T, Perry D E. 1984; Nephelometric methods. Butt W R. Practical immunoassay Marcel Dekker; New York:117–177
    [Google Scholar]
20. Wickerham L J. 1951; Taxonomy of yeasts. Technical Bulletin 1029 U.S. Department of Agriculture; Washington D.C.:
    [Google Scholar]